Management of glucocorticoid-induced osteoporosis: prevalence, and emerging treatment options
Juraj Payer, Kristina Brazdilova, Peter Jackuliak5th Department of Internal Medicine, Medical Faculty of Comenius University and Faculty Hospital Bratislava, Bratislava, SlovakiaAbstract: An excess amount of glucocorticoids represents the primary and most frequent etiological factor influencing seco...
Main Authors: | Juraj Payer, Kristina Brazdilova, Peter Jackuliak |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-05-01
|
Series: | Drug, Healthcare and Patient Safety |
Online Access: | http://www.dovepress.com/management-of-glucocorticoid-induced-osteoporosis-prevalence-and-emerg-a4475 |
Similar Items
-
Osteoporosis, Fractures, and Diabetes
by: Peter Jackuliak, et al.
Published: (2014-01-01) -
Corrigendum to “Osteoporosis, Fractures, and Diabetes”
by: Peter Jackuliak, et al.
Published: (2017-01-01) -
Prevention and treatment of glucocorticoid-induced osteoporosis
by: Milovanović Jasmina R.
Published: (2018-01-01) -
Glucocorticoid-induced osteoporosis
by: Kripa Elizabeth Cherian, et al.
Published: (2017-01-01) -
Glucocorticoid-induced osteoporosis
by: I. S. Dydykina, et al.
Published: (2005-02-01)